Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 12.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 12.92% | |||
| Cost of Revenue | 0.32% | 10.37% | |||
| Gross Profit | 0.32% | 15.15% | |||
| SG&A Expenses | 0.32% | 21.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.32% | -101.30% | |||
| Total Operating Expenses | 0.32% | 14.45% | |||
| Operating Income | 0.32% | -0.59% | |||
| Income Before Tax | 0.32% | -39.30% | |||
| Income Tax Expenses | 0.32% | 273.76% | |||
| Earnings from Continuing Operations | 0.32% | -74.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.32% | 122.31% | |||
| Net Income | 0.32% | -50.87% | |||
| EBIT | 0.32% | -0.59% | |||
| EBITDA | 0.32% | -39.67% | |||
| EPS Basic | 0.00% | -51.47% | |||
| Normalized Basic EPS | 1.64% | 22.00% | |||
| EPS Diluted | 0.00% | -51.47% | |||
| Normalized Diluted EPS | 1.64% | 22.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | 23.08% | |||
| Payout Ratio | 0.00% | 3.08% | |||